Devices, digital health, and the technology changing how care is delivered.
Medical technology company Leo Cancer Care closed a $65 million series D financing round to scale its radiotherapy solution, which uses groundbreaking upright treatment technology.
Performing well in controlled settings is only part of the picture, the harder question is whether AI is being integrated into clinical workflows in ways that keep responsibility, authority, and accountability properly aligned. The post Healthcare and AI are in Need of Relationship Counseling appeared first on MedCity News .
AstraZeneca is paying Sino Biopharmaceutical $200 million upfront for ex-China rights to a late-phase challenger to Merck & Co.’s chronic obstructive pulmonary disease drug Ohtuvayre.
Ascension is set to acquire Williamson Health, a county-owned health system in Tennessee, in a deal worth nearly $1 billion. Ascension’s offer beat out bids from HCA Healthcare and Optum. The post Ascension to Buy Tennessee Health System for Nearly $1B appeared first on MedCity News .
Vertex Pharmaceuticals’ acquisition of Crinetics Pharmaceuticals values the company at about $10 billion. Crinetics’s Palsonify could become a new standard of care therapy for acromegaly and the biotech also brings other drugs in various stages of development for endocrine disorders, a new therapeutic area for Vertex. The post Vertex Pharma’s Growth Strategy Leads to Its Biggest-Ever M&A Deal appeared first on MedCity News .
Contract research organizations (CROs) Caidya and Simbec-Orion have united to create a new platform aimed at helping drug development programs accelerate and scale.
The medical device supplier said that a threat actor accessed company systems through a social engineering attack.
A high rate of continuous glucose monitor adoption and low level of automated insulin delivery system penetration make Spain an attractive market for Insulet.
Diabetes technology news has been off to a fast start this year. Here are some highlights of MedTech Dive’s coverage from 2026.
AI performs best where a problem is well-defined, data-intensive, repetitive and operates at a scale that exceeds human tracking capacity. The supply chain hits all four. The post The AI Use Case That Healthcare is Overlooking appeared first on MedCity News .
Patients, providers, and innovators all benefit from secure, trusted, nationwide data exchange. But this trust cannot sustain itself on fragmented governance or competitive enforcement dynamics. The post The Foundation Is Built — Now We Must Secure the Future of Interoperability appeared first on MedCity News .
As MeiraGTx lines up the pieces for a commercial push, the company has new funding to work with.
Testosterone is not just a “male hormone.” Women need it too. And pretending otherwise has left countless women struggling through midlife while being told everything looks “normal.” The post The Truth About Testosterone in Women: What Medicine Has Overlooked appeared first on MedCity News .
Biocytogen and Whitehawk Therapeutics are joining forces to develop bispecific antibody-drug conjugates using Biocytogen's discovery platform.
Clinical-stage Kalohexis is readying a public listing to support its obesity and cancer cachexia treatments.
Boehringer Ingelheim has landed an exclusive license to Prime Vector Technologies’ viral vector platform for developing next-generation cancer vaccines.
As Novo Nordisk looks for new ways to broaden its semaglutide GLP-1 franchise, the Danish drugmaker has signed a new deal with Californian medtech Vivani Medical to help.
Diagnostics specialist Beckman Coulter expanded its portfolio of Alzheimer’s disease diagnostics by earning a CE mark in Europe for its Access p-Tau217 assay.
As U.S. lawmakers continue to scrutinize the consequences of China’s expanding role in biotech innovation, industry insiders have been left debating how they can navigate this shifting landscape—or even whether biotechs should abandon China altogether.
A new report finds private equity firms are increasingly using joint ventures with nonprofit health systems to expand in healthcare, prompting calls for greater oversight. The post Report Highlights Private Equity’s Lesser-Known Strategy: Nonprofit Joint Ventures appeared first on MedCity News .
Penn Medicine is integrating K Health’s AI-powered patient intake agents into its virtual primary care service. The health system says the goal is to free up time for patient care rather than information-gathering. The post Why Penn Medicine Is Deploying AI Agents for Patient Intake appeared first on MedCity News .
Boston Scientific, Medtronic and Stryker were among the companies to ink deals to move into markets that are expanding quickly.
Healthcare does not lack the data needed to better understand oncology costs. What it does lack is a consistent way to connect clinical progression with financial impact in a time frame that aligns with strategic planning. The post In Oncology, the Cost Problem Goes Beyond Predictability appeared first on MedCity News .
It starts with a simple mindset shift, realizing that a successful AI journey begins with identifying a business problem, not with technology. The plans that make real progress embrace this mindset first then follow these five steps. The post The AI Playbook for Health Plans: 5 Steps for Leaders Who Don’t Know Where to Start appeared first on MedCity News .